Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Response to AASLD editorial/message from the president

Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

DOI

  1. Preemptive-TIPS improves outcome in high-risk variceal bleeding: An observational study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Novel Biomarker Discovery in Non-Alcoholic Steatohepatitis (NASH): Translation of Complex Data into Clear Results

    Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

  3. Viral persistence, liver disease and host response in Hepatitis C-like virus rat model

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Relationship between genetic variation at PPP1R3B and levels of liver glycogen and triglyceride

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Exercise-Based Rehabilitation for Heart Failure: Cochrane Systematic Review, Meta-Analysis, and Trial Sequential Analysis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Plasma expanders for people with cirrhosis and large ascites treated with abdominal paracentesis

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  3. Radix Sophorae flavescentis versus other drugs or herbs for chronic hepatitis B

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  4. Social skills training for attention deficit hyperactivity disorder (ADHD) in children aged 5 to 18 years

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

Vis graf over relationer

A commentary [1] criticized our systematic review regarding the use of direct-acting agents (DAAs) in chronic hepatitis C [2]. The following represents our major disagreements. Sustained virological response (SVR) is a non-validated surrogate outcome. The principles of evidence-based medicine require that it be validated in randomized clinical trials (RCTs) by showing parallel benefits in clinical outcomes [3]. This article is protected by copyright. All rights reserved.

OriginalsprogEngelsk
TidsskriftHepatology (Baltimore, Md.)
Vol/bind69
Udgave nummer5
Sider (fra-til)2300
ISSN0270-9139
DOI
StatusUdgivet - 2019

ID: 57350444